ProCE Banner Activity

First-line Treatment of EGFR Mutation–Positive NSCLC

Slideset Download
Case Challenge
Download this slideset to review key clinical data guiding first-line treatment of patients with EGFR-positive NSCLC, including an expert case discussion and a timeline of evolution of care in this setting.

Released: May 31, 2019

Expiration: May 29, 2020

No longer available for credit.

Share

Faculty

Suresh S. Ramalingam

Suresh S. Ramalingam, MD

Associate Professor
Director,
Division of Medical Oncology
Emory University, Winship Cancer Institute
Atlanta, Georgia

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Suresh S. Ramalingam, MD

Associate Professor
Director,
Division of Medical Oncology
Emory University, Winship Cancer Institute
Atlanta, Georgia